US Patent Issued to Agency for Science, Technology and Research, NATIONAL UNIVERSITY HOSPITAL (SINGAPORE), National University of Singapore on July 14 for "Method of predicting for benefit from immune checkpoint inhibition therapy" (Singaporean Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,680,137, issued on July 14, was assigned to Agency for Science, Technology and Research (Sinagapore, Singapore), NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD (Singapore) and National University of Singapore (Singapore).

"Method of predicting for benefit from immune checkpoint inhibition therapy" was invented by Patrick Tan (Singapore), Raghav Sundar (Singapore), Kie Kyon Huang (Singapore), Aditi Qamra (Singapore), Jonathan Goke (Singapore) and Deniz Demircioglu (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of identifying a patient suffering from cancer as benefiting or not benefiting from immune ...